Towards eradication of measles virus: global progress and strategy evaluation
- PMID: 8588328
- DOI: 10.1016/0378-1135(95)00027-8
Towards eradication of measles virus: global progress and strategy evaluation
Abstract
Despite an increase in global measles vaccine coverage from under 20% in 1980 to around 80% in 1990, measles remains a major cause of morbidity and mortality world-wide. This paper addresses a number of issues relating to efforts to control measles, namely, (i) at the global level, how might we assess the impact of measles vaccination on the incidence of infection and associated disease, and, (ii), at the strategic level, how can we utilise an understanding of the transmission dynamics of childhood viral infections to aid the design of optimal immunisation programmes? Based on WHO vaccine coverage data, and organising countries according to similarities in demographic and epidemiological parameters, an age-structured model of measles transmission is used to capture the non-linear dynamics of infection and mass vaccination and to generate projections of the impact of measles immunization world-wide. The results provide a crude indication of the percentage reduction in measles cases by year 2000 (compared with no immunization) and suggest an approximately 70% reduction in cases over all ages, and 77% reduction in cases under 5 years (where there is the greatest risk of case fatality); these suggest that WHO targets for 1995 are unlikely to be achieved. In the second part of the paper, examples are given to illustrate the usefulness of a modelling approach in evaluating measles immunization policy. The introduction of MMR vaccine in the UK in 1988 has resulted in measles incidence falling to an all time low and attention has turned to the requirements of elimination. A realistic age structured model, validated using extensive serological data, is used to compare the merits of single or two dose strategies. Based upon recent estimates of vaccine efficacy (90%) and coverage (92% by end of second year of life) it is suggested that a two-dose policy with a pre-school second dose given irrespective of vaccine history is required to prevent the build up of susceptibles to epidemic proportions in the longer term. In a second example, prompted by the success of the campaign approach to polio and measles elimination in Central and South America, simple models are used to explore and quantify the process by which pulse vaccination programmes (i.e. repeated application across a wide age range) act to control transmission.
Similar articles
-
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.Epidemiol Infect. 1995 Apr;114(2):319-44. doi: 10.1017/s0950268800057976. Epidemiol Infect. 1995. PMID: 7705494 Free PMC article.
-
Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.Risk Anal. 2017 Jun;37(6):1109-1131. doi: 10.1111/risa.12831. Epub 2017 May 31. Risk Anal. 2017. PMID: 28561947
-
Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.Vaccine. 2013 May 31;31(24):2661-6. doi: 10.1016/j.vaccine.2013.04.014. Epub 2013 Apr 17. Vaccine. 2013. PMID: 23602654
-
[Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].Vopr Virusol. 2004 May-Jun;49(3):8-11. Vopr Virusol. 2004. PMID: 15188648 Review. Russian.
-
Two-dose measles vaccination schedules.Bull World Health Organ. 1993;71(3-4):421-8. Bull World Health Organ. 1993. PMID: 8324862 Free PMC article. Review.
Cited by
-
Evaluating the benefits of increasing measles immunization rates.Health Serv Res. 2001 Oct;36(5):885-909. Health Serv Res. 2001. PMID: 11666109 Free PMC article.
-
Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination.PLoS One. 2012;7(8):e41428. doi: 10.1371/journal.pone.0041428. Epub 2012 Aug 10. PLoS One. 2012. PMID: 22899996 Free PMC article.
-
Measles eradication: is it in our future?Am J Public Health. 2000 Oct;90(10):1521-5. doi: 10.2105/ajph.90.10.1521. Am J Public Health. 2000. PMID: 11029981 Free PMC article.
-
Has the UK government lost the battle over MMR?BMJ. 2005 Mar 12;330(7491):552-3. doi: 10.1136/bmj.330.7491.552. BMJ. 2005. PMID: 15760974 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical